Meta-analysis of Binary Data Using Profile Likelihood

Meta-Analysis of Binary Data Using Profile Likelihood

Volumn , Issue , 2008, Pages 1-190

  Böhning, Dankmar ^a   Kuhnert, Ronny ^b   Rattanasiri, Sasivimol ^c  

^a UNIVERSITY OF READING   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953328203     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (105)

1. Agresti, A. and J. Hartzel (2000). Strategies for comparing treatments on binary response with multicenter data. Statistics in Medicine 19, 1115– 1139.
2. Aitkin, M. (1998). Profile likelihood. In P. Armitage and T. Colton (Eds.), Encyclopedia of Biostatistics, Volume 5, pp. 3534–3536. Chichester, New York: Wiley.
3. Aitkin, M. (1999a). A general maximum likelihood analysis of variance components in generalized linear models. Biometrics 55, 117–128.
4. Aitkin, M. (1999b). Meta-analysis by random effect modelling in generalized linear models. Statistics in Medicine 18, 2343–2351.
5. Antiplatelet Trialists’ Collaboration (1988). Secondary prevention of vascular disease by prolonged antiplatelet treatment. British Medical Journal 296, 320–332.
6. Arends, L. R., A. W. Hoes, J. Lubsen, D. E. Grobbee, and T. Stijnen (2000). Baseline risk as predictor of treatment benefit: Three clinical meta-reanalyses. Statistics in Medicine 19, 3497–3518.
7. Berkey, C., D. Hoaglin, F. Mosteller, and G. Colditz (1995). A random-effects regression model for meta-analysis. Statistics in Medicine 14, 395–411.
8. Berry, S. M. (1998). Understanding and testing for heterogeneity across 2x2 tables: Application to meta-analysis. Statistics in Medicine 17, 2353–2369.
9. Biggerstaff, B. J. and R. L. Tweedie (1997). Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Statistics in Medicine 16, 753–768.
10. Bird, S. M. (2003). European union’s rapid TSE testing in adult cattle and sheep: Implementation and results in 2001 and 2002. Statistical Methods in Medical Research 12, 261–278.
11. Böhning, D. (1992). Multinomial logistic regression algorithm. Annals of the Institute of Statistical Mathematics 44, 197–200.
12. Böhning, D. (2000). Computer-Assisted Analysis of Mixtures and Applications. Meta-Analysis, Disease Mapping and Others. Boca Raton: Chapman & Hall/CRC.
13. Böhning, D. (2003). The EM algorithm with gradient function update for discrete mixtures with known (fixed) number of components. Statistics and Computing 13, 257–265.
14. Böhning, D. and B. G. Lindsay (1988). Monotonicity of quadratic approximation algorithms. Annals of the Institute of Statistical Mathematics 40, 223–224.
15. Böhning, D., U. Malzahn, E. Dietz, P. Schlattmann, C. Viwatwongkasem, and A. Biggeri (2002). Some general points in estimating heterogeneity variance with the DerSimonian-Laird estimator. Biostatistics 3, 445–457.
16. Böhning, D., J. Sarol, S. Rattanasiri, and A. Biggeri (2002). Efficient non-iterative and nonparametric estimation of heterogeneity variance for the standardized mortality ratio. Annals of Institute of Statistical Mathematics 54, 827–839.
17. Böhning, D., J. Sarol, S. Rattanasiri, C. Viwatwongkasem, and A. Biggeri (2004). A comparison of non-iterative and iterative estimators of heterogeneity variance for the standardized mortality ratio. Biostatistics 5, 61–74.
18. Brensen, R. M. D., M. J. A. Tasche, and N. J. D. Nagelkerke (1999). Some notes on baseline risk and heterogeneity in meta-analysis. Statistics in Medicine 18(2), 233–238.
19. Breslow, N. E. (1984). Elementary methods of cohort analysis. International Journal of Epidemiology 13, 112–115.
20. Brockwell, S. E. and I. R. Gordon (2001). A comparison of statistical methods for meta-analysis. Statistics in Medicine 20, 825–840.
21. Brown, H. K. and R. J. Prescott (1999). Applied Mixed Models in Medicine. Chichester, West Sussex, England: Wiley.
22. Bryant, J., B. Fisher, N. Gunduz, J. P. Costantino, and B. Emir (1998). S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor positive breast cancer. Breast Cancer Research and Treatment 51, 239–253.
23. Cochran, W. G. (1954). The combination of estimates from different experiments. Biometrics 10, 101–129.
24. Cochrane Library (2005). The Cochrane Collaboration. http://www3.interscience.wiley.com/aboutus/sharedfiles/cochrane transition: The Cochrane Library.
25. Colditz, G., T. Brewer, C. Berkey, M. Wilson, H. Fineberg, and F. Mosteller (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. meta-analysis of the published literature. Journal of the American Medical Association 271, 698–702.
26. Cooper, H. and L. V. Hedges (1994). The Handbook Research Synthesis. New York: Russell Sage Foundation.
27. Cooper, M. R., K. B. G. Dear, O. R. McIntyre, H. Ozer, J. Ellerton, G. Cannellos, B. Duggan, and C. Schiffer (1993). A randomized clinical trial comparing Melphalan/Prednisone with and without a-2b interferon in newly-diagnosed patients with multiple myeloma: A cancer and leukemia group b study. Journal of Clinical Oncology 11, 155–160.
28. Davey Smith, G., F. Song, and T. A. Sheldon (1993). Cholesterol lowering and mortality: The importance of considering initial level of risk. British Medical Journal 306, 1367–1373.
29. Del Rio Vilas, V. J., P. Hopp, T. Nunes, G. Ru, K. Sivam, and A. Ortiz-Pelaez (2007). Explaining the heterogeneous scrapie surveillance figures across europe: a meta-regression approach. BMC Veterinary Research 3, 13.
30. Del Rio Vilas, V. J., J. Ryan, H. G. Elliott, S. C. Tongue, and J. W. Wilesmith (2005). Prevalence of scrapie in sheep: Results from fallen stock surveys in Great Britain in 2002 and 2003. Veterinary Record 157, 744.
31. Demidenko, E. (2004). Mixed Models. Theory and Applications. Hoboken, New Jersey: Wliey.
32. Dempster, A., N. Laird, and D. B. Rubin (1977). Maximum likelihood estimation from incomplete data via the EM algorithm (with discussion). Journal of the Royal Statistical Society B 39, 1–38.
33. DerSimonian, R. and N. Laird (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177–188.
34. DuMouchel, W. and S.-L. T. Normand (2000). Computer-modeling and graphical strategies for meta-analysis. In D. K. Stangl and D. A. Berry (Eds.), Meta-Analysis in Medicine and Health Policy, pp. 127–178. Basel: Marcel Dekker.
35. Efron, B. (1993). An Introduction to the Bootstrap. London: Chapman & Hall.
36. Egger, M. and G. D. Smith (1995). Risks and benefits of treating mild hypertension: A misleading meta-analysis? [comment]. Journal of Hypertension 13(7), 813–815.
37. Engels, E. A., C. H. Schmid, N. Terrin, I. Olkin, and J. Lau (2000). Heterogeneity and statistical significance in meta-analysis: An empirical study of 125 meta-analyses. Statistics in Medicine 19, 1707–1728.
38. European Commission (2001). Commission regulation (EC) no 1248/2001 of 22 june 2001 amending annexes III, x and XI to regulation (EC) no 999/2001 of the European Parliament and of the council as regards epidemio-surveillance and testing of transmissible spongiform encephalopathies. Official Journal of the European Communities 44, 12–22.
39. European Commission (2004). Report on the monitoring and testing of ruminants for the presence of transmissible spongiform encephalopathy (TSE) in the EU in 2003, including the results of the survey of the prion protein genotypes in sheep breeds. Technical report, Brussels, http://europa.eu.int/comm/foot/food/biosafty/bse/annual report tse2003 en.pdf, accessed on 10.01.2007.
40. European Stroke Prevention Study Group (1987). The european stroke prevention study (ESPS) principal endpoints. Lancet 2, 1351–1354.
41. Foster, J. D., D. Parnham, A. Chong, W. Goldmann, and N. Hunter (2001). Clinical signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats. Veterinary Record 148, 165– 171.
42. Greenland, S. (1994). A critical look at some popular meta-analysis methods. American Journal of Epidemiology 140, 290–296.
43. Greenland, S. and J. M. Robins (1985). Estimation of common effect parameter from sparse follow up data. Biometrics 41, 55–68.
44. Greiner, M. (2000). Serodiagnostische Tests. Berlin, Heidelberg, New York: Springer.
45. Hall, S., R. J. Prescott, R. J. Hallam, S. Dixon, R. E. Harvey, and S. G. Ball (1991). A comparative study of carvedilol, slow release nidedipine and atenolol in the management of essential hypertension. Journal of Pharmacology 18, S36–S38.
46. Hardy, R. J. and S. G. Thompson (1996). A likelihood approach to meta-analysis with random effects. Statistics in Medicine 15, 619–629.
47. Hardy, R. J. and S. G. Thompson (1998). Detecting and describing heterogeneity in meta-analysis. Statistics in Medicine 17, 841–856.
48. Hartung, J., D. Argac, and K. Makambi (2003). Homogeneity tests in meta-analysis. In R. Schulze, H. Holling, and D. Böhning (Eds.), Meta-Analysis: New Developments and Applications in Medical and Social Sciences, pp. 3–20. Göttingen: Hogrefe & Huber.
49. Hartung, J. and G. Knapp (2003). An alternative test procedure for meta-analysis. In R. Schulze, H. Holling, and D. Böhning (Eds.), Meta-Analysis: New Developments and Applications in Medical and Social Sciences, pp. 53–68. Göttingen: Hogrefe & Huber.
50. Hedges, L. V. and J. L. Vevea (1998). Fixed-and random-effects models in meta-analysis. Psychological Methods 3(4), 486–504.
51. Higgins, J. P. T. and S. G. Thompson (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21, 1539–1558.
52. Hine, L. K., N. Laird, P. Hewitt, and T. C. Chalmers (1989). Meta-analytic evidence against prophylactic use of lidocaine in myocardial infarction. Archives of Internal Medicine 149, 2694–2698.
53. Hoes, A. W., D. E. Grobbee, and J. Lubsen (1995). Does drug treatment improve survival? Reconciling the trials in mild-to-moderate hypertension. Journal of Hypertension 13, 805–811.
54. Horwitz, R. I., B. H. Singer, R. W. Makuch, and C. M. Viscoli (1996). Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. Journal of Clinical Epidemiology 49, 395–400.
55. Hunter, N. (2003). Scrapie and experimental BSE in sheep. British Medical Bulletin 66, 171–183.
56. Jackson, D. (2006). The power of standard test for the presence of heterogeneity in meta-analysis. Statistics in Medicine 25, 2688–2699.
57. Jones, D. R. (1992). Meta-analysis of observational epidemiological studies: A review. Journal of the Royal Society of Medicine 85(3), 165–168.
58. Kiefer, J. and J. Wolfowitz (1956). Consistency of the maximum likelihood estimator in the presence of infinitely many incidental parameters. Annals of Mathematical Statistics 27, 886–906.
59. Knapp, G., B. J. Biggerstaff, and J. Hartung (2006). Assessing the amount of heterogeneity in random-effects meta-analysis. Biometrical Journal 48, 271–285.
60. Kuhnert, R. (2005). Untersuchung von Verschiedenen Modellierungen der Heterogenität in Multizentrischen Studien. Ph. D. thesis, Charité Medical School.
61. Lachin, J. M. (2000). Biostatistical Models-The Assessment of Relative Risks. New York: Wiley & Sons.
62. Laird, N. (1978). Nonparametric maximum likelihood estimation of a mixing distribution. Journal of the American Statistical Association 73, 805–811.
63. Lange, K. (2004). Optimization. New York, Berlin, London: Springer.
64. Le, C. T. (1992). Fundamentals of Biostatistical Inference. New York, Basel, Hong Kong: Marcel Dekker, Inc.
65. Lindsay, B. G. (1983). The geometry of mixture likelihoods, part i: A general theory. Annals of Statistics 11, 783–792.
66. Lindsay, B. G. (1995). Mixture Models: Theory, Geometry, and Applications. Institute of Statistical Mathematics, Hayward: NSF-CBMS Regional Conference Series in Probability and Statistics.
67. Lipsitz, S. R., K. B. G. Dear, N. M. Laird, and G. Molenberghs (1998). Tests for homogeneity of the risk difference when data are sparse. Biometrics 54, 148–160.
68. Malzahn, U., D. Böhning, and H. Holling (2000). Nonparametric estimation of heterogeneity variance for the standardised difference used in meta-analysis. Biometrika 87, 619–632.
69. Marshall, R. J. (1991). Mapping disease and mortality rates using empirical Bayes estimators. Applied Statistics 40, 283–294.
70. Martuzzi, M. and M. Hills (1995). Estimating the degree of heterogeneity between event rates unsing likelihood. American Journal of Epidemiology 141, 369–374.
71. McCullagh, P. and J. A. Nelder (1989). Generalized Linear Models (2nd ed.). London: Chapman & Hall.
72. McLachlan, G. and T. Krishnan (1997). The EM Algorithm and Extensions. New York: Wiley.
73. McLachlan, G. and D. Peel (2000). Finite Mixture Models. New York: Wiley.
74. Murphy, S. A. and A. W. Van der Vaart (2000). On profile likelihood. Journal of the American Statistical Association 95, 449–485.
75. Nass, C. A. G. (1959). The chi-square test for small expectations in contingency tables, with special reference to accidents and absenteeism. Biometrika 46, 365–385.
76. Nelder, J. A. and R. W. M. Wedderburn (1972). Generalized linear models. Journal of the Royal Statistical Society, Series A 135, 370–384.
77. Neyman, J. and E. L. Scott (1948). Consistent estimates based on partially consistent observations. Econometrica 16, 1–32.
78. Normand, S. L. T. (1999). Tutorial in biostatistics: Meta-analysis: Formulating, evaluating, combing, and reporting. Statistics in Medicine 18, 321–359.
79. Pawitan, Y. (2001). In All Likelihood. Statistical Modelling and Inference Using Likelihood. Oxford: Clarendon Press.
80. Petitti, D. B. (1994). Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. Methods for Quantitative Synthesis in Medicine. Oxford: Oxford University Press.
81. Pocock, J. S. (1997). Clinical Trials: A Practical Approach. Chichester, New York, Brisbane: John Wiley & Sons.
82. Potthoff, R. F. and M. Whittinghill (1966). Testing for homogeneity i: The binomial and multinomial distributions. Biometrika 53, 167–182.
83. Raudenbush, S. W. (1994). Random effects models. In H. Cooper and L. V. Hedges (Eds.), The Handbook of Research Synthesis, pp. 302–321. New York: Russell Sage Foundation.
84. Scientific Steering Committee (2001). Opinion on Requirements for Statistically Authoritative BSE/TSE Surveys. Adopted by the Scientific Steering Committee at its Meeting of 29-30 November 2001. European Commission, Health & Consumer Protection Directorate-General. http://ec.europa.eu/food/fs/sc/ssc/out238 en.pdf, accessed on 10.01.2007.
85. Selective Decontamination of the Digestive Tract Trialists’ Collaborative Group (1993). Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract. British Medical Journal 307, 525– 532.
86. Sharp, S. J. and S. G. Thompson (2000). Analysing the relationship between treatment effect and underlying risk in meta-analysis: Comparison and development of approaches. Statistics in Medicine 19, 3251–3274.
87. Sharp, S. J., S. G. Thompson, and D. G. Altman (1996). The relation between treatment benefit and underlying risk in meta-analysis. British Medical Journal 313(7059), 735–738.
88. Sidik, K. and J. N. Jonkman (2005). Simple heterogeneity variance estimation for meta-analysis. Journal of Applied Statistical Science 54, 367–384.
89. StataCorp. (2005). Stata statistical software: Release. College Station, TX: StataCorp LP.
90. Stram, D. O. (1996). Meta-analysis of published data using a linear mixed-effects model. Biometrics 52, 536–544.
91. Sutton, A. J., K. R. Abrams, D. Jones, T. A. Sheldon, and F. Song (2000). Methods for Meta-Analysis in Medical Research. New York: John Wiley & Sons, LTD.
92. Thompson, S. G. (1993). Controversies in meta-analysis: The case of the trials of serum cholesterol reduction. Statistical Methods in Medical Research 20, 173–192.
93. Thompson, S. G. (1994). Why sources of heterogeneity in meta-analysis should be investigated. British Medical Journal 309(6965), 1351–1355.
94. Thompson, S. G. and S. J. Sharp (1999). Explaining heterogeneity in meta-analysis: A comparison of methods. Statistics in Medicine 18, 2693–2708.
95. Turner, R., R. Omar, M. Yang, H. Goldstein, and S. Thompson (2000). A multilevel model framework for meta-analysis of clinical trials with binary outcome. Statistics in Medicine 19, 3417–3432.
96. van Houwelingen, H. C., L. R. Arends, and T. Stijnen (2002). Tutorial in biostatistics. Advanced methods in meta-analysis: Multivariate approach and meta-regression. Statistics in Medicine 21, 589–624.
97. van Houwelingen, H. C. and S. Senn (1999). Investigating underlying risk as a source of heterogeneity in meta-analysis (letter). Statistics in Medicine 18, 107–113.
98. van Houwelingen, H. C., K. Zwinderman, and T. Stijnen (1993). A bivariate approach to meta-analysis. Statistics in Medicine 12, 2272–2284.
99. Whitehead, A. (2002). Meta-Analysis of Controlled Clinical Trials. Chichester: Wiley.
100. Whitehead, A. and J. Whitehead (1991). A general parametric approach to the meta-analysis of randomised clinical trials. Statistics in Medicine 10, 1665–1677.
101. Wilesmith, J. W., J. Ryan, V. J. Del Rio Vilas, and S. Gubbins (2004). Summary of the results of scrapie surveillance in sheep in Great Britain, April-December 2003. Weybridge: Veterinary Laboratories Agency. http://www.defra.gov.uk/animalh/bse/othertses/scrapie/scrapiesurvey.pdf, accessed on 10.01.2007.
102. Wilesmith, J. W., G. A. H. Wells, M. P. Cranwell, and J. B. M. Ryan (1988). Bovine spongiform encephalopathy: Epidemiological studies. Veterinary Record 123, 638–644.
103. Will, R. G., J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, and P. G. Smith (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921–925.
104. Woodward, M. (1999). Epidemiology: Study Design and Data Analysis. London, New York, Washington, D.C.: Chapman & Hall/CRC.
105. Yusuf, S., R. Peto, J. Lewis, R. Collins, and P. Sleight (1985). Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovascular Diseases 27, 335–371.